GPT and metabolic dysfunction-associated steatotic liver disease: Notably, even among individuals with normal ALT, NAFLD remains significantly linked to hypertension (OR = 2.03, 95% CI: 1.47–2.80; p ≤ 0.56) and metabolic syndrome (OR = 1.42, 95% CI: 1.00–2.00; p = 0.60).